REQUEST FOR STORAGE AND STABILITY STUDY OF DRUG SUBSTANCES AND PRODUCTS
REQUEST FOR STORAGE AND STABILITY STUDY OF DRUG SUBSTANCES AND PRODUCTS
批准号:
10912133
负责人:
金额:
$0.97万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-08-08 至 2024-01-31
关键词:
AdolescentChild DevelopmentClinicalClinical TrialsCollaborationsContraceptive AgentsContractorContractsEthicsFailureGovernmentGrowth and Development functionHealthInfantKISS1 geneLaboratoriesLongevityMentorsMissionNational Institute of Child Health and Human DevelopmentPersonal SatisfactionPharmaceutical PreparationsPopulationPregnant WomenProtocols documentationReproductionResearchShippingVendorVial deviceVisionWomanWritingcostinnovationmenpopulation healthstability testing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Division of Population Health Research (DiPHR) aims to be a leader in population health research by focusing on successful reproduction, the health and well-being of pregnant women and their infants, and the optimal growth and development of children and adolescents across the lifespan. With the population as its observational laboratory, the division uses collaboration, discovery, ethics, innovation, interdisciplinary teamwork, and mentoring as core values in fulfilling its mission and vision.
NICHD needs a contractor to hold Government owned vials of clinical grade Acyline, bulk clinical grade Acyline and Metastin and bulk research grade Acyline. They will be under stability testing protocol for these vials and bulk substance to support planned and ongoing clinical trials. There is an ongoing need for stability test of the clinical grade vialed and bulk Acyline and Metastin. This is to ensure that the drug substance or product is stable when it goes into clinical trial. These drug products must be stored at -20C, and contracting and shipping them to another vendor is not cost effective. Failure to maintain these drug products would delay ongoing clinical trials and add significant cost to the Government.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金